Outcomes of Upfront Surgery Versus Neoadjuvant Therapy-Preceded Surgery in Patients of Luminal A Breast Cancer with Axillary Nodal Involvement, A Prospective Comparative Study
Oct 2026· International Journal of Drug Delivery Technology· Vol 16· 0 citations
TL;DR
Neoadjuvant chemotherapy has a beneficial effect on nodal status of luminal A EBC patients; constituting for skipping the formal axillary lymph node dissection (ALND) and it does not reduce the breast and axillary post-operative complications to significant values.
Abstract
Background: Luminal A is the most common molecular subtype of breast cancer (BC), in which the neoadjuvant chemotherapy (NAC) is less effective compared to other subtypes. we studied the surgical outcomes of upfront surgery versus the NAC preceded surgery in patients of luminal A early breast cancer (EBC) with axillary nodal involvement. Patients and Methods: It is a prospective comparative randomized study conducted in EL Demerdash Hospital that extended for about two years starting from January 2023. forty female patients with nodal positive early luminal A BC were randomly divided into two equal groups, one of which received NAC before surgery and the other proceeded directly to surgery with a follow up period of about 6 months. Data was analyzed to evaluate short-term outcomes following both strategies. Results: Post NAC clinical nodal conversion was 30% ( p = 0.007), of which four patients (20%) achieved a nodal pathological complete response (NpCR). Reduction in tumor size after NAC was non-significant ( p = 0.081) together with the rate of conversion to breast conservative surgery (BCS), p = 0.308. Post-operative complications were comparable between both groups, with overall morbidity of (35 %) in upfront surgery group compared to (25%) in the NAC one, p = 0.490. Conclusion: Neoadjuvant chemotherapy has a beneficial effect on nodal status of luminal A EBC patients; constituting for skipping the formal axillary lymph node dissection (ALND). Its effect on the breast mass is limited, and it doesn’t reduce the breast and axillary post-operative complications to significant values.
INTRODUCTION
Neoadjuvant chemotherapy (NACT) has been used nationwide in Denmark to downsize tumour and for downstaging of metastases in the axilla. Although several studies have assessed the impact of NACT on surgical complications after immediate breast reconstruction (IBR), the available evidence remains inconsisten...
Sinem Saritaş, A. S. Brems-Eskildsen, Louise Bønnelykke-Behrndtz et al.· Journal of Plastic, Reconstr...· 0 citations
PDS and NACT+IDS offer comparable survival outcomes in patients with advanced EOC, whereas NACT+IDS is associated with improved perioperative safety and higher tumor response rates without increasing severe chemotherapy-related toxicity.
Yong-Hui Zou, Yan-Qiu Wang, Ming-Jun Fan et al.· American Journal of Cancer R...· 0 citations
Comparing the survival outcomes and recurrence patterns of radical surgery and definitive radiotherapy following NICT in patients with LA-ESCC concluded that Definitive RT may be an organ-preserving option in selected patients, especially those with upper esophageal cancer or a favorable response to NICT.
Q. An, Ya-Ge Jia, Meng-Lu Liu et al.· Frontiers in Oncology· 0 citations
Neoadjuvant chemotherapy (NAC) is recommended for patients with muscle-invasive bladder cancer (MIBC); however, its impact on survival outcomes remains controversial in real-world clinical settings. This retrospective observational study evaluated the effect of NAC on pathological outcomes and overall survival among pa...
I. Topcu, Bulut Dural, Ömer Faruk Yıldırım et al.· İnönü Üniversitesi Sağlık Hi...· 0 citations
Purpose.
To compare 3-year survival outcomes in patients with cT4N0M0 breast cancer who achieved ycN0 status after neoadjuvant systemic therapy (NAST), according to the extent of axillary surgery.
Materials and Methods.
This single-center, prospective, nonrandomized cohort study included a historical control g...
M. Kurbanova, V. Amosova, M. Frolova et al.· Malignant tumours· 0 citations
Breast cancer is the most common cancer diagnosed in women worldwide. In high-income countries, breast-conserving surgery combined with radiotherapy gives survival similar to mastectomy in early-stage disease. Whether this holds in low-resource settings such as Libya, where radiotherapy access and follow-up are less co...
Suzan Abusahmen, Fadia Oshkondale, Sumia Draa et al.· AlQalam journal of medical a...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.